Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers
Sergey Nikolaevich Novikov, Irina Aleksandrovna Baldueva, Anton Yurievich Zozulya, Natalya Viktorovna Emelyanova, Dmitriy Viktorovich Girdyuk, Andrey Ivanovich Arsenyev, Elena Alexandrovna, Elena Ivanovna Tyuryaeva, E. I. Filip Evgenevich Antipov, Mikhail Markovich Girshovich, Sergey Vasilevich Kanayev
Radiat Oncol J. 2023;41(1):23-31. Published online 2023 Feb 27 DOI: https://doi.org/10.3857/roj.2022.00521
Citations to this article as recorded by 
IFN-Type-I Response and Systemic Immunity in Rectal Adenocarcinoma Patients Treated with Conventional or Hypofractionated Neoadjuvant Radiotherapy
Ioannis M. Koukourakis, Erasmia Xanthopoulou, Michael I. Koukourakis, Dina Tiniakos, Vassilis Kouloulias, Anna Zygogianni
Biomolecules.2024; 14(4): 448. CrossRef
Oligo-Metastatic Disease in Oncology: Exploring the Limits and the Potential of Genetic Assessment
Mariachiara Santorsola, Maurizio Capuozzo, Giovanni Savarese, Monica Ianniello, Nadia Petrillo, Marika Casillo, Francesco Sabbatino, Francesco Perri, Francesco Ferrara, Andrea Zovi, Massimiliano Berretta, Vincenza Granata, Guglielmo Nasti, Alessandro Otta
Genes.2023; 14(12): 2131. CrossRef
Radiotherapy and blockade of immune checkpoints in treatment of cancer patients
I.А. Hromakova, P.P. Sorochan, V.P. Starenkyi, N.E. Prokhach, I.S. Hromakova
Український радіологічний та онкологічний журнал.2023; 31(4): 440. CrossRef